PlyoPulse EMS RCT Shows Objective Functional Gains

Key Takeaways

• PlyoPulse EMS triggered 68% increase in hip‑extension reps by week 5.
• All four objective tests showed significant between‑group gains favoring treatment at week 5.
• Functional improvements persisted through week 9 (four weeks post‑final session).

What does the trial show about PlyoPulse EMS?

A randomized controlled trial published in Aesthetic Surgery Journal (peer‑reviewed ahead of print in August 2026) found that PlyoPulse EMS produced objective gains in muscle function. The study, titled "Functional Performance, Subject‑Body Perception, and Safety Following Multi‑Muscle Electromuscular Stimulation," enrolled 38 healthy adults and randomized them into six weekly PlyoPulse sessions versus untreated controls. Evaluators blind‑tested functional performance at baseline, at week 5 (pre‑final treatment), and at week 9 (four weeks post‑treatment).

The treatment group increased prone hip extension repetitions by 68% (P<0.001), paced curl‑up reps by 42% (P=0.0025), seated quadriceps extension by 53% (P<0.001), and side plank endurance by 73% (P=0.0018). All four tests showed statistically significant between‑group differences at week 5 (P<0.01 for three, P=0.0146 for curl‑ups). Most gains held through week 9. The study recorded Body‑Q improvements in body image and satisfaction, with 68% of treated subjects reporting stronger muscles. Discomfort stayed low (mean 1.2/10) and no adverse events occurred (sofwave.com).

How does PlyoPulse differ from traditional EMS?

PlyoPulse uses synchronized multi‑muscle activation with rotating polarity and programmable duty cycles to stimulate anatomically related muscle groups—abdomen, glutes, quadriceps, hamstrings—simultaneously. Traditional EMS devices drive repetitive contractions in isolated muscles. PlyoPulse aims to mimic plyometric recruitment patterns, not single‑direction twitching (sofwave.com).

How durable are the functional improvements?

The trial measured outcomes at week 9, four weeks after the final PlyoPulse session. Most functional performance gains persisted at that point, with three out of four between‑group differences remaining statistically significant. The untreated control group showed little or no change over that time (sofwave.com).

FAQ

What is PlyoPulse EMS?

PlyoPulse EMS is a multi‑muscle electrical stimulation technology integrated into Sofwave's Pure Impact VIP platform. It delivers synchronized stimulation across groups like abdomen, glutes, quadriceps, and hamstrings.

How soon do functional gains appear with PlyoPulse EMS?

The published randomized controlled trial found significant functional performance gains by week 5, after completing five of six weekly sessions.

Are the improvements long‑lasting?

The trial shows most functional gains remained statistically significant at week 9, four weeks after the treatment series ended.

Was the study randomized and controlled?

Yes. The study enrolled 38 healthy adults randomized equally into a PlyoPulse EMS treatment group and an untreated control group; evaluators were blinded during functional testing.

Was treatment safe and comfortable?

Yes. The study reported low mean discomfort (1.2 out of 10), 82% of sessions with none‑to‑minimal discomfort, and no adverse events.

Where was the study published?

It appeared ahead‑of‑print in Aesthetic Surgery Journal in August 2026 under the title "Functional Performance, Subject‑Body Perception, and Safety Following Multi‑Muscle Electromuscular Stimulation."

Not medical advice. Aesthetic treatment results vary by individual. Consult a licensed, qualified provider before pursuing any cosmetic procedure.